Search Results
Overview
| Uniprot ID | P08684 |
|---|---|
| Protein Name | Cytochrome P450 3A4 |
| Gene Name | CYP3A4 |
| Organism | Homo sapiens |
Kla Sites from experimental identification
| Position | Flanking peptide |
|---|---|
| 141 | SPTFTSGKLKEMVPI |
| 143 | TFTSGKLKEMVPIIA |
| 168 | RREAETGKPVTLKDV |
| 266 | SRLEDTQKHRVDFLQ |
| 379 | RLERVCKKDVEINGM |
| 413 | KYWTEPEKFLPERFS |
| 466 | VLQNFSFKPCKETQI |
| 469 | NFSFKPCKETQIPLK |
| 66 | MFDMECHKKYGKVWG |
| 96 | MIKTVLVKECYSVFT |
Function
A cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids (PubMed:10681376, PubMed:11093772, PubMed:11555828, PubMed:12865317, PubMed:14559847, PubMed:15373842, PubMed:15764715, PubMed:19965576, PubMed:20702771, PubMed:21490593, PubMed:21576599). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds (PubMed:12865317, PubMed:14559847, PubMed:15373842, PubMed:15764715, PubMed:21490593, PubMed:21576599, PubMed:2732228). Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C-16 position (PubMed:11555828, PubMed:12865317, PubMed:14559847). Plays a role in the metabolism of androgens, particularly in oxidative deactivation of testosterone (PubMed:15373842, PubMed:15764715, PubMed:22773874, PubMed:2732228). Metabolizes testosterone to less biologically active 2beta- and 6beta-hydroxytestosterones (PubMed:15373842, PubMed:15764715, PubMed:2732228). Contributes to the formation of hydroxycholesterols (oxysterols), particularly A-ring hydroxylated cholesterol at the C-4beta position, and side chain hydroxylated cholesterol at the C-25 position, likely contributing to cholesterol degradation and bile acid biosynthesis (PubMed:21576599). Catalyzes bisallylic hydroxylation of polyunsaturated fatty acids (PUFA) (PubMed:9435160). Catalyzes the epoxidation of double bonds of PUFA with a preference for the last double bond (PubMed:19965576). Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling (PubMed:20702771). Plays a role in the metabolism of retinoids. Displays high catalytic activity for oxidation of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA) (PubMed:10681376). Further metabolizes atRA toward 4-hydroxyretinoate and may play a role in hepatic atRA clearance (PubMed:11093772). Responsible for oxidative metabolism of xenobiotics. Acts as a 2-exo-monooxygenase for plant lipid 1,8-cineole (eucalyptol) (PubMed:11159812). Metabolizes the majority of the administered drugs. Catalyzes sulfoxidation of the anthelmintics albendazole and fenbendazole (PubMed:10759686). Hydroxylates antimalarial drug quinine (PubMed:8968357). Acts as a 1,4-cineole 2-exo-monooxygenase (PubMed:11695850). Also involved in vitamin D catabolism and calcium homeostasis. Catalyzes the inactivation of the active hormone calcitriol (1-alpha,25-dihydroxyvitamin D(3)) (PubMed:29461981)
Protein Sequence
Gene Ontology
| Classification | GO ID | Description |
|---|---|---|
| Cellular Component | GO:0005737 | cytoplasm |
| Cellular Component | GO:0005789 | endoplasmic reticulum membrane |
| Cellular Component | GO:0043231 | intracellular membrane-bounded organelle |
| Molecular Function | GO:0102320 | 1,8-cineole 2-exo-monooxygenase activity |
| Molecular Function | GO:0062181 | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity |
| Molecular Function | GO:0062188 | anandamide 11,12 epoxidase activity |
| Molecular Function | GO:0062189 | anandamide 14,15 epoxidase activity |
| Molecular Function | GO:0062187 | anandamide 8,9 epoxidase activity |
| Molecular Function | GO:0034875 | caffeine oxidase activity |
| Molecular Function | GO:0019899 | enzyme binding |
| Molecular Function | GO:0101020 | estrogen 16-alpha-hydroxylase activity |
| Molecular Function | GO:0101021 | estrogen 2-hydroxylase activity |
| Molecular Function | GO:0020037 | heme binding |
| Molecular Function | GO:0005506 | iron ion binding |
| Molecular Function | GO:0004497 | monooxygenase activity |
| Molecular Function | GO:0016491 | oxidoreductase activity |
| Molecular Function | GO:0019825 | oxygen binding |
| Molecular Function | GO:0050591 | quinine 3-monooxygenase activity |
| Molecular Function | GO:0008401 | retinoic acid 4-hydroxylase activity |
| Molecular Function | GO:0005496 | steroid binding |
| Molecular Function | GO:0008395 | steroid hydroxylase activity |
| Molecular Function | GO:0050649 | testosterone 6-beta-hydroxylase activity |
| Molecular Function | GO:0070576 | vitamin D 24-hydroxylase activity |
| Molecular Function | GO:0030343 | vitamin D3 25-hydroxylase activity |
| Biological Process | GO:0046222 | aflatoxin metabolic process |
| Biological Process | GO:0009822 | alkaloid catabolic process |
| Biological Process | GO:0008209 | androgen metabolic process |
| Biological Process | GO:0008203 | cholesterol metabolic process |
| Biological Process | GO:0008210 | estrogen metabolic process |
| Biological Process | GO:0002933 | lipid hydroxylation |
| Biological Process | GO:0006629 | lipid metabolic process |
| Biological Process | GO:0042759 | long-chain fatty acid biosynthetic process |
| Biological Process | GO:0016098 | monoterpenoid metabolic process |
| Biological Process | GO:0070989 | oxidative demethylation |
| Biological Process | GO:0042573 | retinoic acid metabolic process |
| Biological Process | GO:0042572 | retinol metabolic process |
| Biological Process | GO:0006706 | steroid catabolic process |
| Biological Process | GO:0008202 | steroid metabolic process |
| Biological Process | GO:0042369 | vitamin D catabolic process |
| Biological Process | GO:0042359 | vitamin D metabolic process |
| Biological Process | GO:0042178 | xenobiotic catabolic process |
| Biological Process | GO:0006805 | xenobiotic metabolic process |
Reference
[1] Yang Z, Yan C, Ma J, Peng P, Ren X et al.. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma.. Nat Metab 5(1):61-79. 2023 Jan. PMID: 36593272.
[2] Hong H, Chen X, Wang H, Gu X, Yuan Y et al.. Global profiling of protein lysine lactylation and potential target modified protein analysis in hepatocellular carcinoma.. Proteomics 23(9):e2200432. 2023 May. PMID: 36625413.